| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 15 | +66.67% | +0.35% | -1.17% | +1.52% | -1.18% | — |
| 14d | 15 | +46.67% | +3.60% | -0.09% | +3.69% | +1.80% | — |
| 30d | 15 | +46.67% | +8.48% | +0.24% | +8.24% | +1.34% | — |
| 60d | 15 | +33.33% | +9.58% | +0.13% | +9.46% | +7.64% | — |
| 90d | 15 | +46.67% | +10.34% | +2.40% | +9.12% | +12.30% | — |
| 180d | 15(5 pending) | +50.00% | +54.88% | +7.08% | +47.80% | +7.26% | — |
| 1y | 15(7 pending) | +37.50% | +154.95% | +21.30% | +133.65% | +225.08% | — |
| 2y | 15(12 pending) | +100.00% | -68.42% | +46.67% | -115.09% | -134.79% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 373,295 | — | — | 373,295 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 248,865 | — | — | 3,583,548 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 29,282 | $14.48 | $424.1K | 3,334,683 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 15,500 | $14.68 | $227.6K | 3,363,965 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 2,818 | $7.57 | $21.3K | 3,381,439 | Jan 16, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 2,818 | — | — | 0 | Jan 16, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 1,974 | $13.83 | $27.3K | 3,379,465 | Jan 16, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 197,182 | — | — | 2,818 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 197,182 | $7.57 | $1.49M | 3,514,814 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 136,193 | $13.59 | $1.85M | 3,378,621 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 7,715 | $11.09 | $85.6K | 3,317,632 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 200 | $15.00 | $3.0K | 3,325,347 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 29,733 | $14.34 | $426.5K | 3,325,547 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 21,490 | $3.47 | $74.5K | 3,355,280 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 270,177 | — | — | 270,177 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 180,118 | — | — | 3,376,770 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 4,595 | $3.17 | $14.5K | 3,196,652 | Mar 3, 2025 | Mar 5, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 11,851 | $3.47 | $41.1K | 3,201,247 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 7,471 | $4.05 | $30.2K | 3,213,098 | Jan 6, 2025 | Jan 8, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 18,589 | $3.20 | $59.4K | 3,220,569 | Sep 30, 2024 | Oct 2, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 1,857 | — | — | 0 | Sep 23, 2024 | Sep 25, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 1,857 | $1.57 | $2.9K | 3,239,158 | Sep 23, 2024 | Sep 25, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 34,449 | — | — | 1,857 | Sep 12, 2024 | Sep 16, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 34,449 | $1.57 | $54.1K | 3,237,301 | Sep 12, 2024 | Sep 16, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 179,850 | — | — | 3,202,852 | Apr 16, 2024 | Apr 18, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 380,000 | — | — | 380,000 | Apr 16, 2024 | Apr 18, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 4,135 | $18.73 | $77.4K | 3,023,002 | Mar 5, 2024 | Mar 7, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 190,000 | — | — | 190,000 | Feb 26, 2024 | Feb 28, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 126,667 | — | — | 3,027,137 | Feb 26, 2024 | Feb 28, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 5,841 | $16.33 | $95.4K | 2,900,470 | Jan 9, 2024 | Jan 11, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 63,694 | — | — | 36,306 | Nov 16, 2023 | Nov 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 63,694 | $1.57 | $100.0K | 2,906,311 | Nov 16, 2023 | Nov 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 2,842,617 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 225,000 | — | — | 225,000 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 96,076 | $31.84 | $3.06M | 2,796,541 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 3,924 | $32.45 | $127.3K | 2,792,617 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 4,122 | $36.08 | $148.7K | 2,894,463 | Jan 6, 2023 | Jan 10, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 1,846 | $36.79 | $67.9K | 2,892,617 | Jan 6, 2023 | Jan 10, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 334,520 | $0.37 | $123.8K | 2,898,585 | May 5, 2022 | May 6, 2022 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 334,520 | — | — | 0 | May 5, 2022 | May 6, 2022 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 337,500 | — | — | 337,500 | Jan 6, 2022 | Jan 10, 2022 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Co-Chief Executive Officer | 4,870 | — | — | 0 | Jan 6, 2022 | Jan 10, 2022 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE Co-Chief Executive Officer | 4,870 | — | — | 2,489,065 | Jan 6, 2022 | Jan 10, 2022 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 2,564,065 | Jan 6, 2022 | Jan 10, 2022 ↗ | View → |